CER-1236
CER-1-1
Phase 1 small_molecule active
Quick answer
CER-1236 for AML is a Phase 1 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- AML
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active